Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Roivant Sciences (ROIV) Net Margin (2020 - 2024)

Roivant Sciences' Net Margin history spans 5 years, with the latest figure at 3626.3% for Q4 2024.

  • For Q4 2024, Net Margin rose 400232.0% year-over-year to 3626.3%; the TTM value through Sep 2025 reached 2563.05%, up 260767.0%, while the annual FY2025 figure was 1284.5%, 224787.0% up from the prior year.
  • Net Margin reached 3626.3% in Q4 2024 per ROIV's latest filing, up from 962.75% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 3626.3% in Q4 2024 to a low of 8191.34% in Q2 2022.
  • Average Net Margin over 5 years is 1798.24%, with a median of 1516.12% recorded in 2023.
  • Peak YoY movement for Net Margin: plummeted -688458bps in 2022, then skyrocketed 667522bps in 2023.
  • A 5-year view of Net Margin shows it stood at 4792.99% in 2020, then soared by 74bps to 1257.49% in 2021, then crashed by -79bps to 2257.19% in 2022, then surged by 83bps to 376.01% in 2023, then soared by 1064bps to 3626.3% in 2024.
  • Per Business Quant, the three most recent readings for ROIV's Net Margin are 3626.3% (Q4 2024), 962.75% (Q3 2024), and 1115.06% (Q2 2024).